Creatine and the creatine transporter: a review

Prior research has shown that creatine and its phosphate form play essential roles in energy metabolism across multiple tissues. Established knowledge indicates that creatine concentrations influence both functional and structural properties in neural, cardiac, and skeletal muscle. However, the mechanisms controlling cellular creatine levels remain poorly understood. No prior work had resolved how creatine transporter gene expression is regulated across tissues. This gap motivated investigations into the CreaT1 and CreaT2 genes. It was already known that CreaT1 transcripts appear in diverse tissues, but CreaT2 is limited to testes. The functional significance of CreaT protein glycosylation remains unclear. That uncertainty drove the need to examine transporter activity regulation in detail.

This review aimed to evaluate literature on how cellular creatine content is regulated. The focus was on the creatine transporter's gene expression and activity. The study sought to clarify the roles of CreaT1 and CreaT2 in different tissues. The researchers propose that understanding these transporters could reveal how creatine levels are maintained. The review also examined factors influencing transporter activity, such as hormones and Na+ gradients. The goal was to synthesize current findings on transporter regulation. The authors suggest that intracellular creatine levels may influence gene expression. This work aimed to highlight gaps in understanding transporter regulation.

The review synthesized existing literature on creatine transporter regulation. The study analyzed chromosomal location and DNA sequencing of CreaT1 and CreaT2. The authors examined tissue-specific expression patterns of these genes. They evaluated how substrate concentration and transmembrane gradients affect transporter activity. The review included recent data on CreaT1 protein expression in various tissues. The authors considered hormonal influences and phosphorylation effects on transporters. The study also explored the potential role of glycosylation in transporter function. The review approach focused on summarizing evidence from molecular and physiological studies.

CreaT1 transcripts are found in multiple tissues, while CreaT2 is testes-specific. The CreaT proteins have putative structures based on DNA sequencing. There is limited data on factors regulating CreaT gene expression. Intracellular creatine levels may influence transporter regulation, but this remains unclear. Transporter activity is affected by substrate concentration and Na+ gradients. Hormones and plasma membrane interactions likely modulate CreaT function. Glycosylation of CreaT proteins varies across cells, but functional significance is unknown. These findings suggest that transporter regulation is complex and multifactorial.

The authors propose that CreaT1 and CreaT2 have distinct tissue-specific roles. They suggest that transporter activity is modulated by multiple physiological factors. The review highlights gaps in understanding gene regulation mechanisms. The authors emphasize the need for further research on CreaT function in different tissues. They note that glycosylation patterns may influence transporter activity. The findings suggest that hormonal and ionic gradients are important regulatory elements. The authors conclude that current evidence is insufficient to fully explain transporter regulation. The review underscores the importance of future studies on CreaT gene expression.